News
Brandon Capital on board as Parkinson’s smartwatch firm Global Kinetics seeks $30 million
Emerging Australian medtech success story Global Kinetics is raising $20-30 million to keep commercialising its smartwatch-style Parkinson’s treatment device. The company is also working on an expansion into telehealth in partnership with French hospitals and developing an app to give Parkinson’s patients more control over their own treatment. Read more
Read MoreBrandon Capital on board as Parkinson’s smartwatch firm Global Kinetics seeks $30 million
Emerging Australian medtech success story Global Kinetics is raising $20-30 million to keep commercialising its smartwatch-style Parkinson’s treatment device. The company is also working on an expansion into telehealth in partnership with French hospitals and developing an app to give Parkinson’s patients more control over their own treatment. Read more
Read MoreHas cancer finally met its match?
Jamie Morton goes inside the immunotherapy revolution. Let’s not mince words: it’s a barn-storming, breathless revolution.” Professor Graham Le Gros doesn’t mean to come off sounding over the top. It’s just he’s palpably excited about the promise of an area of medical research we hear too little about. Read more
Read MoreSuperhero Saturday to help fight Superbugs
Customers visiting Briscoes or Rebel Sport stores this weekend could find themselves served at the checkout by Superman, Wonder Woman or possibly even Captain America with staff donning superhero outfits all in aid of fighting superbugs. The dress-up day is part of Briscoe Group’s charity partner Cure Kids’ appeal “Fight Against Superbugs’ to raise funds…
Read MoreAnti-TB drug resistance threatens to unwind the progress
There is no doubt that groundbreaking progress has been made in fight against tuberculosis (TB) in the past two decades, but it might be prudent to review if we are winning the fight in order to #endTB by 2030. Do we slip backwards when we fail to prevent every single transmission of new TB infection…
Read MoreCRISPR gene editing puts the brakes on cancer cells
Cancer cells are known for their fast and rapacious growth, but a new technique to slow them down may one day offer new treatment options. Scientists from the US have discovered a protein called Tudor-SN linked to the “preparatory” phase of cell life – when cells prepare to divide and spread. Read more
Read MoreNew Gait Test Could Predict Early Dementia
In a new study, researchers at Lawson Health Research Institute and Western University are demonstrating that gait, or motion testing, while simultaneously performing a cognitively demanding task can predict dementia and eventually help with earlier diagnosis. To date, there is no definitive way for health care professionals to forecast the onset of dementia in a…
Read MoreCloud giants form alliance to accelerate genome research
BGI Online is a cloud platform for genomics data analysis. At the Bio-IT World Conference and Expo in Boston this week, BGI announced that they will work alongside Broad Institute, Intel and Alibaba Cloud in an effort to bring cloud-based and free access to the to the latest version of the Genome Analysis Tool Kit…
Read MoreSupercomputer study unlocks secrets of brain and safer anaesthetics
Researchers have used a supercomputer to show how proteins in the brain control electrical signals, in a breakthrough that could lead to safer and more effective drugs and anaesthetics. In the seven-year study just released, RMIT University researchers – led by Professor Toby Allen and including Dr Bogdan Lev and Dr Brett Cromer – modelled…
Read MoreHealth Research Matters May 2017
Click here to view the May newsletter
Read More